Biomarkers may help ID treatment of acute kidney injury
Hospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment.
A UW Medicine-led study published recently in American Journal of Kidney Diseases suggests that new tests might improve this narrative.
In the study, “about 30% of the patients that came into the hospital developed AKI, which means in a matter of hours or days, their kidneys might be failing because of reaction to drugs or contracting sepsis,” said lead author Dr. Pavan Bhatraju, an assistant professor of pulmonary and critical care medicine at the University of Washington School of Medicine.
Causes ...









